Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-22 to 2022-05-13
Current total value of award: $12498.09
Description: 4556999438!OMIDRIA 1-0.3% VIAL 4ML